Daniela Grases Mendoza

Daniela Grases Mendoza

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
PPPaolo Petazzi
Paolo Petazzi
OJOlga de la Caridad Jorge-Torres
Olga de la Caridad Jorge-Torres
AGAntonio Gomez
Antonio Gomez
ISIolanda Scognamiglio
Iolanda Scognamiglio
JSJordi Serra-Musach
Jordi Serra-Musach
SGSònia Guil
Sònia Guil
Rett syndrome (RTT) is a severe neurodevelopmental disease caused almost exclusively by mutations to the MeCP2 gene. This disease may be regarded as a synaptopathy, with impairments affecting synaptic plasticity, inhibitory and excitatory transmission and network excitability. The complete understanding of the mechanisms behind how the transcription factor MeCP2 so profoundly affects the mammalian brain are yet to be determined. What is known, is that MeCP2 involvement in activity-dependent expression programs is a critical link between this protein and proper neuronal activity, which allows the correct maturation of connections in the brain. By using RNA-sequencing analysis, we found several immediate-early genes (IEGs, key mediators of activity-dependent responses) directly bound by MeCP2 at the chromatin level and upregulated in the hippocampus and prefrontal cortex of the Mecp2-KO mouse. Quantification of the IEGs response to stimulus both in vivo and in vitro detected an aberrant expression pattern in MeCP2-deficient neurons. Furthermore, altered IEGs levels were found in RTT patient’s peripheral blood and brain regions of post-mortem samples, correlating with impaired expression of downstream myelination-related genes. Altogether, these data indicate that proper IEGs expression is crucial for correct synaptic development and that MeCP2 has a key role in the regulation of IEGs.

19 June 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
MSMustafa Sibai
Mustafa Sibai
SCSergi Cervilla
Sergi Cervilla
DMDaniela Grases Mendoza
Daniela Grases Mendoza
EMEva Musulen
Eva Musulen
RLRossana Lazcano
Rossana Lazcano
EPEduard Porta-Pardo
Eduard Porta-Pardo
Tumors are complex ecosystems with dozens of interacting cell types. The concept of Cancer Hallmarks distills this complexity into a set of underlying principles that govern tumor growth. Here, we exploit this abstraction to explore the physical distribution of Cancer Hallmarks across 63 primary untreated tumors from 10 cancer types using spatial transcriptomics. We show that Hallmark activity is spatially organized–with 7 out of 13 Hallmarks consistently more active in cancer cells than within the non-cancerous tumor microenvironment (TME). The opposite is true for the remaining six Hallmarks. Additionally, we discovered that genomic distance between tumor subclones correlates with differences in Cancer Hallmark activity, even leading to clone-Hallmark specialization in some cases. Finally, we demonstrate interdependent relationships between Cancer Hallmarks at the junctions of TME and cancer compartments. In conclusion, including the spatial dimension, particularly through the lens of Cancer Hallmarks, can improve our understanding of tumor ecology. Significance: We explored Cancer Hallmarks in 63 primary untreated tumors from 10 cancer types using spatial transcriptomics. This study unveiled spatial patterns in Hallmark activity, with some being more active in cancer cells and others in the non-cancerous tumor environment. Genomic distance impacted Hallmark activity, and we identified interdependencies at the TME-cancer junctions, improving our understanding of tumor ecology.

17 April 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
EPEduard Porta-Pardo
Eduard Porta-Pardo
DMDaniela Grases Mendoza
Daniela Grases Mendoza
Spatial transcriptomics enables the in situ mapping of gene expression, revolutionizing our ability to study tissue organization and cellular interactions. However, as this technology is increasingly adopted across biological and clinical research, many groups struggle with practical barriers to implementation—including platform selection, sample quality, and experimental scalability.Here, we provide a comprehensive, practical guide to spatial transcriptomics, informed by the processing and analysis of over 1,000 spatial samples across Visium, Visium HD, and Xenium platforms. We outline best practices for experimental design, tissue handling, sequencing, and computational analysis, with special attention to clinical samples and high-throughput settings.Our goal is to translate hands-on experience into actionable recommendations that support robust, reproducible spatial workflows. This guide is designed to assist researchers at all levels—from those designing their first spatial experiment to groups aiming to integrate ST into translational pipelines and large-scale studies.

4 July 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
CGCarlos A. Garcia-Prieto
Carlos A. Garcia-Prieto
EMEva Musulen
Eva Musulen
VDVerónica Dávalos
Verónica Dávalos
GFGerardo Ferrer
Gerardo Ferrer
DMDaniela Grases Mendoza
Daniela Grases Mendoza
MEManel Esteller
Manel Esteller
Severe Coronavirus disease 2019 (COVID-19) induces heterogeneous and progressive diffuse alveolar damage (DAD) highly disrupting lung tissue architecture and homeostasis, hampering disease management leading to fatal outcomes. Characterizing DAD pathophysiology across disease progression is of ultimate importance to better understand the molecular and cellular features driving different DAD patterns and to optimize treatment strategies. To contextualize the interplay between cell types and assess their distribution, spatial transcriptomics (ST) techniques have emerged, allowing unprecedented resolution to investigate spatial architecture of tissues. To this end, post-mortem lung tissue provides valuable insights into cellular composition and their spatial relationships at the time of death. Here, we have leveraged VisumST technology in post-mortem COVID-19 induced acute and proliferative DAD lungs including control samples with normal morphological appearance, to unravel the immunopathological mechanisms underlying DAD, providing novel insights into cellular and molecular communication events driving DAD progression in fatal COVID-19. We report a progressive loss of endothelial cell types, pneumocytes type I and natural killer cells coupled with a continuous increase of myeloid and stromal cells, mostly peribronchial fibroblasts, over disease progression. Spatial organization analysis identified variable cellular compartments, ranging from major compartments defined by cell type lineages in control lungs to increased and more specific compartmentalization including immune-specific clusters across DAD spectrum. Importantly, spatially informed ligand-receptor interaction (LRI) analysis revealed an intercellular communication signature defining COVID-19 induced DAD lungs. Transcription factor (TF) activity enrichment analysis identified TGF-B pathway as DAD driver, highlighting SMAD3 and SMAD7 TFs activity role during lung fibrosis. Integration of deregulated LRIs and TFs activity allowed us to propose a downstream intracellular signaling pathway in peribronchial fibroblasts, suggesting potential novel therapeutic targets. Finally, spatio-temporal trajectories analysis provided insights into the alveolar epithelium regeneration program, characterizing markers of pneumocytes type II differentiation towards pneumocytes type I. In conclusion, we provide a spatial characterization of lung tissue architecture upon COVID-19 induced DAD progression, identifying molecular and cellular hallmarks that may help optimize treatment and patient management.

6 October 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
SCSergi Cervilla
Sergi Cervilla
DMDaniela Grases Mendoza
Daniela Grases Mendoza
NMNoelia Montesdeoca
Noelia Montesdeoca
AFAlbert Font
Albert Font
MFMaria Fernández-Saorin
Maria Fernández-Saorin
EPEduard Porta-Pardo
Eduard Porta-Pardo
Spatial transcriptomics is increasingly used to infer cellular phenotypes, molecular interactions, and functional tissue organization from RNA, although most of these biological processes are ultimately mediated by proteins. Here, we directly tested the interchangeability of spatial RNA and protein measurements using paired Xenium profiling of 21 matched targets across ∼1.8 million cells from primary lung adenocarcinoma and metastatic castration-resistant prostate cancer. After accounting for marker- and dataset-specific protein background, we quantified concordance at multiple levels, including single-cell detection, expression magnitude, cell-type distribution, patient-level abundance, and spatial organization. Agreement at single-cell level was strongly marker-dependent. Canonical lineage markers generally showed concordant RNA and protein patterns, whereas several molecules, including in our study PD-1, PD-L1, and LAG-3, showed little concordance across modalities. Importantly, spatial organization remained substantially more discordant between modalities than overall abundance, indicating that spatial biomarkers are not directly transferable across modalities. Together, our results show that spatial RNA and protein measurements provide largely overlapping information for lineage markers and overall abundance, but can diverse for specific molecules and for higher-order spatial features, where the two layers provide complementary rather than equivalent readouts. These findings provide practical guidance on when spatial transcriptomic readouts can be interpreted as proxies for protein and when orthogonal protein validation is advisable.

5 March 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
KIKathleen Jane Imbach
Kathleen Jane Imbach
SGSergi Cervilla Garcia
Sergi Cervilla Garcia
DMDaniela Grases Mendoza
Daniela Grases Mendoza
SBSara Bystrup
Sara Bystrup
AFArola Fortian
Arola Fortian
JBJordi Barretina
Jordi Barretina
Acquired resistance to poly(ADP-ribose) polymerase inhibitors (PARPi) remains a major barrier to durable clinical benefit in patients with high-grade serous ovarian cancer (HGSOC), yet the profiles of tumors at resistance remain poorly understood. We profiled longitudinal HGSOC patient tumors spanning diagnosis, post-neoadjuvant therapy, and progression on PARPi with complementary spatial transcriptomics platforms, integrating single-cell–resolution Xenium analysis in paired longitudinal cases with cohort-level Visium profiling. PARPi failure was associated with spatial remodeling of the tumor microenvironment, marked by hypoxia-associated malignant transcriptional programs, increased stromal compartmentalization, and exclusion of effector immune cells. Together, these findings indicate that PARPi resistance in HGSOC is accompanied by reproducible spatial niche remodeling, underscoring the tumor microenvironment as a key contextual determinant of therapeutic failure.